135 related articles for article (PubMed ID: 7905249)
1. Fetal vascular atrial natriuretic peptide receptors in human placenta: alteration in intrauterine growth retardation and preeclampsia.
Kingdom JC; McQueen J; Ryan G; Connell JM; Whittle MJ
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):142-7. PubMed ID: 7905249
[TBL] [Abstract][Full Text] [Related]
2. Vascular angiotensin II and atrial natriuretic peptide receptors in normal and growth-retarded human placentae.
McQueen J; Kingdom JC; Jardine AG; Connell JM; Whittle MJ
J Endocrinol; 1990 Aug; 126(2):341-7. PubMed ID: 2169524
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features.
Salafia CM; Minior VK; Pezzullo JC; Popek EJ; Rosenkrantz TS; Vintzileos AM
Am J Obstet Gynecol; 1995 Oct; 173(4):1049-57. PubMed ID: 7485292
[TBL] [Abstract][Full Text] [Related]
4. Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation.
Kingdom JC; McQueen J; Connell JM; Whittle MJ
Br J Obstet Gynaecol; 1993 May; 100(5):476-82. PubMed ID: 8518250
[TBL] [Abstract][Full Text] [Related]
5. Fetal endothelin levels and placental vascular endothelin receptors in intrauterine growth retardation.
McQeen J; Kingdom JC; Connell JM; Whittle MJ
Obstet Gynecol; 1993 Dec; 82(6):992-8. PubMed ID: 8233278
[TBL] [Abstract][Full Text] [Related]
6. CD15 as a marker of fetoplacental endothelial immaturity in IUGR placentas.
Ravikumar G; Crasta J; Prabhu JS; Thomas T; Dwarkanath P; Thomas A; Kurpad AV; Sridhar TS
J Matern Fetal Neonatal Med; 2019 May; 32(10):1646-1653. PubMed ID: 29251202
[TBL] [Abstract][Full Text] [Related]
7. [The relation between the levels of serum lipid peroxide, superoxide dismutase and atrial natriuretic peptide in placenta, umbilical cord vein and intrauterine growth retardation in pregnancy induced hypertension].
Zhao SC
Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):278-80, 314. PubMed ID: 8243146
[TBL] [Abstract][Full Text] [Related]
8. Characterization of atrial natriuretic peptide receptors in human fetoplacental vasculature.
McQueen J; Kingdom JC; Whittle MJ; Connell JM
Am J Physiol; 1993 Mar; 264(3 Pt 2):H798-804. PubMed ID: 8096122
[TBL] [Abstract][Full Text] [Related]
9. Impaired fetoplacental angiogenesis in growth-restricted fetuses with abnormal umbilical artery doppler velocimetry is mediated by aryl hydrocarbon receptor nuclear translocator (ARNT).
Su EJ; Xin H; Yin P; Dyson M; Coon J; Farrow KN; Mestan KK; Ernst LM
J Clin Endocrinol Metab; 2015 Jan; 100(1):E30-40. PubMed ID: 25343232
[TBL] [Abstract][Full Text] [Related]
10. Perinatal factors influencing atrial natriuretic peptide levels in umbilical arterial plasma at the time of delivery.
Castro LC; Arora CP; Roll KE; Sassoon DA; Hobel CJ
Am J Obstet Gynecol; 1989 Sep; 161(3):623-7. PubMed ID: 2528907
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of placental neuropilin-1 in fetal growth restriction.
Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
[TBL] [Abstract][Full Text] [Related]
12. In vitro effect of bioactive natriuretic peptides on perfusion pressure in placentas from normal and pre-eclamptic pregnancies.
Szukiewicz D; Szukiewicz A; Maslinska D; Markowski M
Arch Gynecol Obstet; 1999 Nov; 263(1-2):37-41. PubMed ID: 10728627
[TBL] [Abstract][Full Text] [Related]
13. An increase of the plasma N-terminal peptide of proatrial natriuretic peptide in preeclampsia.
Pouta AM; Vuolteenaho OJ; Laatikainen TJ
Obstet Gynecol; 1997 May; 89(5 Pt 1):747-53. PubMed ID: 9166314
[TBL] [Abstract][Full Text] [Related]
14. Aberrant pro-atrial natriuretic peptide/corin/natriuretic peptide receptor signaling is present in maternal vascular endothelium in preeclampsia.
Gu Y; Thompson D; Xu J; Lewis DF; Morgan JA; Cooper DB; McCathran CE; Wang Y
Pregnancy Hypertens; 2018 Jan; 11():1-6. PubMed ID: 29523263
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
Knock GA; Sullivan MH; McCarthy A; Elder MG; Polak JM; Wharton J
J Pharmacol Exp Ther; 1994 Nov; 271(2):1007-15. PubMed ID: 7965763
[TBL] [Abstract][Full Text] [Related]
16. Intraplacental villous artery resistance indices and identification of placenta-mediated diseases.
Babic I; Ferraro ZM; Garbedian K; Oulette A; Ball CG; Moretti F; Gruslin A
J Perinatol; 2015 Oct; 35(10):793-8. PubMed ID: 26226247
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide donors in pregnancy: fetomaternal hemodynamic effects induced in mild pre-eclampsia and threatened preterm labor.
Luzi G; Caserta G; Iammarino G; Clerici G; Di Renzo GC
Ultrasound Obstet Gynecol; 1999 Aug; 14(2):101-9. PubMed ID: 10492869
[TBL] [Abstract][Full Text] [Related]
18. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action.
Myatt L; Rosenfield RB; Eis AL; Brockman DE; Greer I; Lyall F
Hypertension; 1996 Sep; 28(3):488-93. PubMed ID: 8794838
[TBL] [Abstract][Full Text] [Related]
19. Low-dose infusion of atrial natriuretic peptide in the conscious guinea pig increases blood flow to the placenta of growth-retarded fetuses.
Jansson TB
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):213-8. PubMed ID: 1531099
[TBL] [Abstract][Full Text] [Related]
20. Expression of C-type natriuretic peptide in human placenta and myometrium in normal pregnancies and pregnancies complicated by intrauterine growth retardation. Preliminary results.
Stepan H; Faber R; Stegemann S; Schultheiss HP; Walther T
Fetal Diagn Ther; 2002; 17(1):37-41. PubMed ID: 11803215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
